InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by HANTSON LUDWIG. Officer active across 3 companies, notably ALEXION PHARMACEUTICALS, INC.. Aggregated, 8 filings have been recorded. Activity tracked since 14 July 2021. The latest transaction was filed on 21 July 2021 (Disposition). Regulator: SEC (Form 4). All data is openly available.
8 of 8 declarations
Hantson Ludwig is a director at Alexion Pharmaceuticals, Inc. and Hologic Inc.